Registered Clinical Trials Underway
Drink HRW has many clinical trials currently underway, or in planning. Some of these ongoing trials have been registered, whereas others have not required registration (particularly those for athletic performance and recovery).
Below you will find a sample of some of the clinical trials using Drink HRW tablets that are currently underway. This list is not a complete list of ongoing research in humans. Typically, research regarding athletic performance and recovery is not registered, and some other trials may not require registration, which is at each primary investigator’s and institution’s discretion.
Hydrogen water is being explored for possible benefits to various factors associated with aging, in a population of 70+ individuals. The studies will follow 34 individuals for 6 months in a double-blind, placebo-controlled manner, initiated by the University of Novi Sad in Serbia.
Hydrogen water, produced by Drink HRW tablets, is being explored in three registered clinical trials initiated by StonyBrook Medicine in New York:
Hydrogen water consumption post-stroke recovery, 100 participants
Hydrogen water for participants with Parkinson’s Disease, 70 participants
Hydrogen water on measurements of quality of life on patients with high-grade gliomas who are undergoing chemotherapy and radiation therapy, 15 participants
Molecular hydrogen being explored for possible benefits in preventing the runaway inflammatory reactions that lead to complications of Covid-19, 450 participants
Molecular hydrogen being explored for possible benefits in the reduction in complications from COVID-19 in a randomized controlled trial